Claro Surgical, a groundbreaking company in the field of orthopedic and trauma surgery, has recently emerged from stealth mode with an innovative mixed reality platform that is revolutionizing the way surgeries are performed. The platform, which is already in use on live patients in Europe and is now launching in the United States, utilizes real-time 3D guidance viewed through XR headsets to replace traditional X-ray shots during drilling and screw placement.
The company has seen rapid adoption of its technology, with twelve successful surgeries in Europe, over one hundred surgeons trained, and commitments from ten hospitals within just two weeks of its U.S. debut. This commercial release marks a significant milestone in the quest for “X-ray vision for surgery,” a concept that has been pursued by various companies over the past decade without widespread adoption. While surgical robotics have improved precision in procedures like joint replacements, many fracture repairs still rely on intermittent fluoroscopy and manual alignment.
The founders of Claro Surgical, Moises Ramos and Dr. Joan Ferras, attribute the success of their platform to its unique delivery model. Instead of introducing new hardware or specialized robots, the company’s software runs on existing headsets like HoloLens, Quest, and Apple Vision Pro. The headsets’ outward-facing cameras map the patient and operating room, while Claro’s database recognizes standard orthopedic implants and drills, overlaying a 3D path that guides surgeons in their procedures without the need for pre-operative CT scans.
Clinical testing on synthetic bone has shown impressive results, with five independent surgeons reducing drilling time by eighty-six percent and improving accuracy by eighty-seven percent. These results have translated seamlessly to live procedures, where surgeons have praised the platform for its ability to provide real-time guidance and improve workflow efficiency.
Claro Surgical has garnered significant interest from investors, raising $1.5 million earlier this year primarily from orthopedic surgeons and former medtech founders. The company plans to announce a seed round in the coming weeks, followed by a $25 million Series A next year. With a focus on licensing the software to hospitals on an annual contract basis, Claro aims to streamline fracture repair procedures, standardize outcomes, and reduce costs associated with traditional X-ray imaging.
As the company continues to grow, it plans to expand its team and further develop its platform to target the highest-volume segment of orthopedics: fracture repair. By providing surgeons with a clearer view of their procedures through mixed reality technology, Claro Surgical is poised to revolutionize the field of orthopedic surgery and improve patient outcomes worldwide.
